Replies to post #49901 on Innovation Pharmaceuticals Inc (IPIX)

[Pontoon]

Dr J, Why is it that you affect some of us on this board in strange and irritating ways. Personally, whenever I read your posts I want to go pour myself a large glass of red followed by a deep and quieting toke, inhaled to the knees. You unsettle me.
I'll take you at your word that you have about as many shares of CTIX as I do, and that you own shares also in other Biotechs. But you blow hot and cold, like a pump n' dump. No one expects you to proclaim a rocket ride and you speak in tech language that compels a listen, like one would to a real doctor, if that is what you are. But you blow too hot, then cold. One wonders where you are 'at'. Would you please give your readers, including myself, a year end overview of where you really are 'at' with CTIX, what you expect for pps in the coming year and thereafter and WHY. Otherwise I just may have to shut off your posts, at risk of becoming a drunk or pothead should I continue reading such erratic material as you provide on this link.



Show me one post where I state I sold one single share of CTIX please...

I am long with almost 36,000 shares with average cost of 1.28

I will be here and long until this is done , never flipped and never sold one single share.

I am a realist and I follow this company's development carefully.

I don't care when people post the rocket ship nonsense and yes I do own shares of Tesaro,
Celgene, Cubist, Ariad, Biogen, and Amarantus

[mdphd2008]

Dr. Jerry, I am also Long on CTIX, have been a follower for over 3 years, have accumulated a very substantial position.

Over the past few years, I have been increasingly comfortable increasing my position as CTIX expands their pipeline, making my investment less risky with the chances of successful product(s) exponentially more likely.

Although, I am not expecting a full out buyout of CTIX in the very short term, which may be very enticing for many of the desperate large pharmas out there that have been unsuccessful with their own R&D, would a $2 Billion price tag be unrealistic for a company with so many potential drugs in clinical trials with such large potential profitable markets?!? Moreover, a $2 Billion price tag would translate to approximately a $20 per share price.

Perhaps, it is time we all get together for a group deal on some good tax/estate lawyers!!!!